Organon announced on April 15, 2025, the appointment of Ramona A. Sequeira to its Board of Directors, effective July 1, 2025. Ms. Sequeira, President of the Global Portfolio Division at Takeda Pharmaceutical Company, will serve on the Board’s Talent Committee.
Ms. Sequeira brings over 30 years of pharmaceutical industry expertise, including 20 years at Eli Lilly and Company and 10 years at Takeda. Her experience spans commercial leadership and strategy development across global markets, including the USA, Europe, and Emerging Markets.
The addition of Ms. Sequeira, a proven commercial leader, is expected to strengthen Organon's Board as the company continues to pursue growth opportunities for its diverse portfolio. Her appointment expands the size of Organon’s Board to 12 directors.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.